Seres Therapeutics (1S90) Cash flow

1 Followers

Seres Therapeutics Cash Flow

DE:1S90's free cash flow for Q4 2025 was $-14.74M. For the 2025 fiscal year, DE:1S90's free cash flow was decreased by $149.85M and operating cash flow was $-14.71M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ 1.12M	$ -148.61M	$ -117.35M	$ -228.82M	$ 6.69M
Investing Cash Flow	$ -42.00K	$ 142.29M	$ 10.58M	$ 82.43M	$ 64.09M
Financing Cash Flow	$ 13.90M	$ -90.37M	$ 71.70M	$ 129.60M	$ 1.18M
End Cash Position	$ 54.43M	$ 39.46M	$ 136.15M	$ 171.22M	$ 188.00M
Free Cash Flow	$ 865.00K	$ -148.99M	$ -125.33M	$ -238.64M	$ -2.88M

Currency in USD